XJSENTC
Market cap1.09bUSD
Dec 20, Last price
1,499.00ZAR
1D
-0.20%
1Q
3.38%
Jan 2017
-52.92%
Name
Netcare Ltd
Chart & Performance
Profile
Netcare Limited, an investment holding company, operates private hospitals in South Africa. The company operates through Hospital and Emergency Services, and Primary Care segments. The Hospital and Emergency Services segment engages in the hospital and pharmacy operations. Its operations covers its private acute hospital network and day clinics; and non-acute services, including emergency medical services, private mental health clinics operation, diagnostics support services, and cancer care services, as well as sells healthcare products and vouchers. The Primary Care segment offers healthcare services, and employee health and wellness services, as well as administrative services to medical and dental practices. The company also engages in the financing, property owing, and pharmaceutical services. It operates through a network of 51 hospitals; 2 public-private partnership hospitals; 10,605 registered hospital beds; 422 theaters; 10 cancer care centers; 63 renal dialysis units with 860 dialysis stations; 95 primary healthcare centers; 15 medicross day theaters; 79 netcare 911 emergency sites; 7 netcare training campuses; and 12 mental health and psychiatric clinics with 841 beds. Netcare Limited was incorporated in 1996 and is headquartered in Sandton, South Africa.
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
Income | ||||||||||
Revenues | 25,202,000 6.34% | 23,699,000 9.54% | 21,636,000 2.06% | |||||||
Cost of revenue | 22,384,000 | 21,308,000 | 19,656,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 2,818,000 | 2,391,000 | 1,980,000 | |||||||
NOPBT Margin | 11.18% | 10.09% | 9.15% | |||||||
Operating Taxes | 591,000 | 471,000 | 484,000 | |||||||
Tax Rate | 20.97% | 19.70% | 24.44% | |||||||
NOPAT | 2,227,000 | 1,920,000 | 1,496,000 | |||||||
Net income | 1,499,000 19.25% | 1,257,000 24.09% | 1,013,000 31.73% | |||||||
Dividends | (766,000) | |||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (722,000) | (461,000) | ||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 2,334,000 | 1,908,000 | 1,691,000 | |||||||
Long-term debt | 15,856,000 | 15,383,000 | 13,659,000 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 576,000 | 514,000 | 555,000 | |||||||
Net debt | 15,947,000 | 14,551,000 | 13,334,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,869,000 | 1,880,000 | 2,612,000 | |||||||
CAPEX | (1,463,000) | (1,443,000) | (1,382,000) | |||||||
Cash from investing activities | (1,154,000) | (1,306,000) | (1,248,000) | |||||||
Cash from financing activities | (1,191,000) | (599,000) | (1,325,000) | |||||||
FCF | 1,038,000 | 975,000 | 1,301,000 | |||||||
Balance | ||||||||||
Cash | 1,819,000 | 2,294,000 | 1,501,000 | |||||||
Long term investments | 424,000 | 446,000 | 515,000 | |||||||
Excess cash | 982,900 | 1,555,050 | 934,200 | |||||||
Stockholders' equity | 14,715,000 | 14,967,000 | 14,448,000 | |||||||
Invested Capital | 23,214,100 | 22,298,950 | 21,277,800 | |||||||
ROIC | 9.79% | 8.81% | 7.07% | |||||||
ROCE | 11.52% | 9.92% | 8.79% | |||||||
EV | ||||||||||
Common stock shares outstanding | 1,345,000 | 1,348,000 | ||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 4,150,000 | 3,663,000 | 3,141,000 | |||||||
EV/EBITDA | ||||||||||
Interest | 1,206,000 | 1,001,000 | 713,000 | |||||||
Interest/NOPBT | 42.80% | 41.87% | 36.01% |